Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Autoimmune Blistering Disease”

14 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 14 of 14 results

Testing effectiveness (Phase 2)Study completedNCT07461103
What this trial is testing

Effect of Topical Insulin on Healing Rate of Pemphigus Lesions

Who this might be right for
Pemphigus VulgarisSkin ErosionAutoimmune Blistering Disease
Alexandria University 20
Large-scale testing (Phase 3)Ended earlyNCT04612790
What this trial is testing

Investigate the Use of Benralizumab in Patients With Bullous Pemphigoid.

Who this might be right for
Bullous Pemphigoid
AstraZeneca 67
Post-approval studies (Phase 4)Study completedNCT05984381
What this trial is testing

Efficacy and Safety of add-on Dapsone Versus add-on Methotrexate in Patients With Bullous Pemphigoid

Who this might be right for
Bullous Pemphigoid
All India Institute of Medical Sciences, Bhubaneswar 62
Testing effectiveness (Phase 2)Study completedNCT02226146
What this trial is testing

Evaluation of Safety, Efficacy and Pharmacodynamic Effect of Bertilimumab in Patients With Bullous Pemphigoid

Who this might be right for
Pemphigoid, Bullous
Alexion Pharmaceuticals, Inc. 11
Testing effectiveness (Phase 2)Study completedNCT00584935
What this trial is testing

Clinical Trial Evaluating Rituximab in Ocular Cicatricial Pemphigoid

Who this might be right for
Ocular Cicatricial Pemphigoid
University of Alabama at Birmingham 3
Not applicableActive Not RecruitingNCT05286242
What this trial is testing

Evaluating the Immune Response to COVID19 Vaccination in Immunodeficient Patients

Who this might be right for
Multiple SclerosisAutoimmune Blistering DiseaseB-Cell Deficiency
Yale University 400
Testing effectiveness (Phase 2)Ended earlyNCT01930175
What this trial is testing

Study of Efficacy and Safety of VAY736 in Patients With Pemphigus Vulgaris

Who this might be right for
Pemphigus Vulgaris
Novartis Pharmaceuticals 13
Large-scale testing (Phase 3)WithdrawnNCT05061771
What this trial is testing

Nomacopan Therapy in Adult Patients With Bullous Pemphigoid Receiving Adjunct Oral Corticosteroid Therapy (ARREST-BP)

Who this might be right for
Bullous Pemphigoid
AKARI Therapeutics
Testing effectiveness (Phase 2)Ended earlyNCT01571895
What this trial is testing

Pilot Efficacy and Safety Study of Oral DF2156A in Patients With Active Bullous Pemphigoid

Who this might be right for
Bullous Pemphigoid
Dompé Farmaceutici S.p.A 4
Not applicableLooking for participantsNCT02753777
What this trial is testing

Autoimmune Blistering Diseases Study

Who this might be right for
Pemphigus VulgarisPemphigus FoliaceusBullous Pemphigoid
University of Pennsylvania 150
Early research (Phase 1)Study completedNCT03306589
What this trial is testing

Lipopolysaccharide (LPS) or Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) Challenge Study on Healthy Subjects

Who this might be right for
Arthritis, Rheumatoid
GlaxoSmithKline 12
Not applicableStudy completedNCT03856840
What this trial is testing

Cytokines in Blister Fluids of Bullous Pemphigoid (BP)

Who this might be right for
Pemphigoid, Bullous
Mahmut Can Koska 21
Not applicableStudy completedNCT00001505
What this trial is testing

The Acquisition of Blood and Skin Samples From Normal Volunteers to Support Research Activities on Dermatologic Diseases

Who this might be right for
Healthy VolunteerDermatologic DiseasesSystemic Diseases
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) 304
Very early researchEnded earlyNCT01313923
What this trial is testing

Evaluating Sirolimus to Treat Autoimmune Blistering Dermatosis Pemphigus

Who this might be right for
Pemphigus
University of California, Irvine 3